138 Combination of PI3K inhibitor BAY 80-6946 with allosteric MEK inhibitor BAY 86-9766 (RDEA119) and with erlotinib for the treatment of non-small cell lung cancer

✍ Scribed by N. Liu; F. Puehler; A. Haegebarth; A. Scholz; J. Hoffmann; D. Mumberg; K. Ziegelbauer

• Book ID: 119602820
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 43 KB
• Volume: 8
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(10)71843-7